Legal DNA Testing Latest News,Prices and Information

CLOSING GLANCE: BIOTECHNOLOGY (AP)

Shares of biotechnology companies closed higher Wednesday as the broader markets finished mixed over continued concerns about the financial sector and a decline in oil prices.

ERBITUX’S DECEPTIVELY DISAPPOINTING RESULTS (AT MOTLEY FOOL)

EXPANDING POSSIBILITIES FAIL TO EXPAND RIGEL’S STOCK PRICE (AT MOTLEY FOOL)

AVASTIN VASTLY IMPROVES GENENTECH (ZACKS.COM)

OPENING GLANCE: BIOTECHNOLOGY (AP)

Shares of biotechnology companies opened mixed Wednesday with the broader market. Here's how several key biotechnology stocks performed Wednesday:

CANCER REVOLUTION, OR ME-TOO MESS? (AT FORBES.COM)

MOODY’S IS GLOOMY ON U.S. DRUGMAKERS’ CREDIT (AT THE WALL STREET JOURNAL ONLINE)

CLOSING GLANCE: BIOTECHNOLOGY (AP)

Shares of pharmaceutical companies closed mixed Tuesday as the broader market declined on reports that investment bank Lehman Brothers Holdings Inc. may raise cash.

BIOTECH STOCKS: DRUG STOCKS EDGE HIGHER AS SCHERING-PLOUGH CLIMBS (AT MARKETWATCH)

Drug stocks inch higher, with shares of Schering-Plough climbing as its polio drug compound begins testing.

OPENING GLANCE: BIOTECHNOLOGY (AP)

Shares of biotechnology companies opened mixed Tuesday, following the broader market, after Federal Reserve Chairman Ben Bernanke reiterated his outlook for improvements in the economy later this year.